A case of postmenopausal bleeding with an unusual finding


  • Samar Rudra Department of Obstetrics and Gynecology, Dr. D. Y. Patil Medical College and Hospital, Dr. D. Y. Patil Vidyapeeth, Pimpri, Pune, Maharashtra, India
  • Manasi Mukund Thakur Department of Obstetrics and Gynecology, Dr. D. Y. Patil Medical College and Hospital, Dr. D. Y. Patil Vidyapeeth, Pimpri, Pune, Maharashtra, India




Adnexal mass, Endometrial hyperplasia, Granulosacell tumour, Inhibin B, Ovarian tumour, Postmenopausal bleeding


Authors report the case of a 55-year-old patient who presented with postmenopausal bleeding. On clinical evaluation uterus was 12 weeks size with a left sided adnexal cystic mass of 8 × 6 cm size. Further imaging studies revealed uterus size of 11.5 × 6.7 × 6.3 cm, left ovarian mass of size 8.4 × 6.7 × 6 cm and endometrial thickness of 17 mm on ultrasonography. She underwent endometrial biopsy to exclude endometrial cancer. The report of which came to be endometrial hyperplasia without atypia. Further MRI study confirmed the findings of USG of a complex cystic lesion of left adnexa 75 × 57 × 60 mm. Tumor marker for ovarian tumors were sent and inhibin B was found to be markedly raised. A provisional diagnosis of GCT (Granulosa cell tumour) was made and staging laparotomy was done. The uterus was found to be 12 × 8 cm size and a left sided ovarian cyst of 8-9 cm size with smooth wall and intact capsule was found. Patient had an uneventful postoperative recovery.


Reed SD, Newton KM, Clinton WL, Epplein M, Garcia R, Allison K, et al. Incidence of endometrial hyperplasia. Am J Obstet Gynecol. 2009;200:678.e1-6.

Gruber SB, Thompson WD. A population-based study of endometrial cancer and familial risk in younger women. Cancer and Steroid Hormone Study Group. Cancer Epidemiol Biomarkers Prev. 1996;5:411-7.

Segal R, DePetrillo AD, Thomas G. Clinical review of adult granulosa cell tumors of the ovary. Gynecol Oncol. 1995;56:338-44.

Vyas MN, Manjeera L, Rai S. Delayed menopause due to ovarian granulosa cell tumour. J Clin Diag Res. 2013;7(10):2306-7.

Miller BE, Barron BA, Wan JY, Delmore JE, Silva EG, Gershenson DM, et al. Prognostic factors in adult granulosa cell tumor of the ovary. Cancer. 1997;79:1951-5.

Lappohn RE, Burger HG, Bouma J. Inhibin as a marker for granulosa-cell tumors. N Engl J Med. 1989;321:790-3.

Hildebrandt RH, Rouse RV, Longacre TA. Value of inhibin in the identification of granulosa cell tumors of the ovary. Hum Pathol. 1997;28:1387-95.

Mom CH, Engelen MJ, Willemse PH, Gietema JA, Ten Hoor KA, de Vries EG, et al. Granulosa cell tumors of the ovary: The clinical value of serum inhibin A and B levels in a large single center cohort. Gynecol Oncol. 2007;105(2):365-72.

Scully RE, Young RH, Clement PB. Tumors of the ovary, maldeveloped gonads, fallopian tube, and broad ligament. In: Atlas of Tumor Pathology. Washington, DC: Armed Forces Institute of Pathology; 1998;23:3rd series.

Ukah CO, Ikpeze OC, Eleje GU, Eke AC. Adult granulosa cell tumor associated with endometrial carcinoma: a case report. J Med Case Reports. 2011;5:340.

Malmström H, Högberg T, Risberg B, Simonsen E. Granulosa cell tumors of the ovary: Prognostic factors and outcome. Gynecol Oncol. 1994;52:50-5.

Shah SP, Köbel M, Senz J. Mutation of FOXL2 in granulosa-cell Tumors of the ovary. N Engl J Med. 2009;360:2719-29.

Wolf JK, Mullen J, Eifel PJ, Burke TW, Levenback C, Gershenson DM. Radiation treatment of advanced or recurrent granulosa cell tumor of the ovary. Gynecol Oncol. 1999;73:35-41.

Hardy RD, Bell JG, Nicely CJ, Reid GC. Hormonal treatment of a recurrent granulosa cell tumor of the ovary: Case report and review of the literature. Gynecol Oncol. 2005;96:865-9.

Korach J, Perri T, Beiner M, Davidzon T, Fridman E, Ben-Baruch G. Promising effect of aromatase inhibitors on recurrent granulosa cell tumors. Int J Gynecol Cancer. 2009;19:830-3.

Rey RA, Lhomme C, Marcillac I, Lahlou N, Duvillard P, Josso N, Bidart JM. Antimullerian hormone as a serum marker of granulosa cell tumors of the ovary: comparative study with serum alpha-inhibin and estradiol. Am J Obstet Gynecol. 1996;174:958-65.






Case Reports